DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 NGS Genetic DNA Test
Introduction
The DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 NGS Genetic DNA Test is a revolutionary diagnostic tool designed to identify mutations in the DOCK7 gene that are linked to severe neurological disorders, specifically early infantile epileptic encephalopathy. This test utilizes Next Generation Sequencing (NGS) technology to provide accurate and comprehensive genetic insights, which are crucial for the timely diagnosis and management of affected infants.
What the Test Measures
This genetic test detects specific mutations in the DOCK7 gene, which can cause early infantile epileptic encephalopathy type 23. By analyzing the genetic material, clinicians can determine if a child is at risk for this disorder, allowing for early intervention and tailored treatment plans.
Who Should Consider This Test
This test is recommended for infants exhibiting symptoms such as:
- Frequent seizures or convulsions
- Developmental delays
- Unexplained neurological symptoms
Additionally, families with a history of epilepsy or neurological disorders should consider this test for early detection and management.
Benefits of Taking the Test
- Early diagnosis allows for timely medical intervention, improving outcomes.
- Identifies genetic causes of seizures, aiding in effective treatment planning.
- Provides families with valuable information for understanding their child’s condition.
- Facilitates genetic counseling for family planning and risk assessment.
Understanding Your Results
Results from the DOCK7 Gene test will indicate the presence or absence of mutations in the DOCK7 gene. A positive result may confirm the diagnosis of early infantile epileptic encephalopathy type 23, while a negative result can help rule out this genetic condition. It is essential to discuss your results with a healthcare provider for proper interpretation and guidance.
Test Details and Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 NGS Genetic DNA Test | 400,000 NGN | 560,000 NGN |
Booking the Test
To book the DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 NGS Genetic DNA Test, please contact us at +2348077798758. Our team is ready to assist you with the booking process and provide any necessary information regarding pre-test instructions and genetic counseling.
Turnaround Time and Sample Type
The turnaround time for this test is approximately 3 to 4 weeks. The sample type required can be blood, extracted DNA, or one drop of blood on an FTA card.
Pre-Test Instructions
Before undergoing the test, it is essential to have a clinical history of the patient and attend a genetic counseling session to draw a pedigree chart of family members affected by the DOCK7 gene-related conditions.
By choosing the DOCK7 Gene Early Infantile Epileptic Encephalopathy Type 23 NGS Genetic DNA Test, you are taking a significant step towards understanding and managing your child’s health. Book your test today!
